Open access
Open access
Powered by Google Translator Translator

Oncology (all articles)

SR | Partial breast irradiation for breast cancer

3 Feb, 2023 | 14:06h | UTC

Partial Breast Irradiation for Breast Cancer – Agency for Healthcare Research and Quality

 


RCT | First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma

3 Feb, 2023 | 14:02h | UTC

First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma: a randomized, double-blind phase 3 trial – Nature Medicine

 


M-A | Treatment- and immune-related AEs of checkpoint inhibitors in esophageal or gastroesophageal junction cancer

3 Feb, 2023 | 13:55h | UTC

Treatment- and immune-related adverse events of immune checkpoint inhibitors in esophageal or gastroesophageal junction cancer: A network meta-analysis of randomized controlled trials – Frontiers in Oncology

 


M-A | Major complications and mortality after resection of intrahepatic cholangiocarcinoma

3 Feb, 2023 | 13:43h | UTC

Major complications and mortality after resection of intrahepatic cholangiocarcinoma: A systematic review and meta-analysis – Surgery

 


M-A | Risk of non-hormonal cancer after bariatric surgery

2 Feb, 2023 | 14:37h | UTC

Risk of non-hormonal cancer after bariatric surgery: meta-analysis of retrospective observational studies – British Journal of Surgery (link to abstract – $ for full-text)

Commentary: Bariatric Surgery May Reduce the Risk of Some Common Cancers – National Cancer Institute

 


M-A | Short-and long-term outcomes of laparoscopic versus open gastrectomy in patients with gastric cancer

2 Feb, 2023 | 14:36h | UTC

Short-and long-term outcomes of laparoscopic versus open gastrectomy in patients with gastric cancer: a systematic review and meta-analysis of randomized controlled trials – World Journal of Surgical Oncology

 


Preliminary study suggests chemotherapy delivery in the afternoon may improve outcomes in patients with DLBC lymphoma

1 Feb, 2023 | 13:27h | UTC

Chemotherapy delivery time affects treatment outcomes of female patients with diffuse large B cell lymphoma – JCI Insight

Commentaries:

Receiving Chemotherapy in the Afternoon May Improve Treatment Outcomes in Some Patients With DLBCL – The ASCO Post

Chemotherapy schedule affects treatment outcomes in female DLBCL patients – News Medical

 


SR | Immediate breast reconstruction uptake in older women with primary breast cancer

1 Feb, 2023 | 13:04h | UTC

Immediate breast reconstruction uptake in older women with primary breast cancer: systematic review – British Journal of Surgery

 


M-A | Immunotherapy or targeted therapy as the first-line strategies for unresectable hepatocellular carcinoma

31 Jan, 2023 | 13:42h | UTC

Immunotherapy or targeted therapy as the first-line strategies for unresectable hepatocellular carcinoma: A network meta-analysis and cost-effectiveness analysis – Frontiers in Immunology

 


SR | There is insufficient evidence to recommend corticosteroids for the management of cancer‐related fatigue

30 Jan, 2023 | 00:47h | UTC

Corticosteroids for the management of cancer‐related fatigue in adults with advanced cancer – Cochrane Library

Summary: What are the benefits and risks of using corticosteroid medicines in the treatment of fatigue related to advanced cancer? – Cochrane Library

 


RCT | Adjuvant temozolomide with or without interferon alfa in patients with newly diagnosed high-grade gliomas

30 Jan, 2023 | 00:27h | UTC

Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade Gliomas: A Randomized Clinical Trial – JAMA Network Open

Commentary: Interferon Alfa Improves Upon Standard Care in High Grade Glioma – Cancer Therapy Advisor

 

Commentary on Twitter

 


Cohort Study | Risk of malignant neoplasms of the gastrointestinal tract after blood or marrow transplant

30 Jan, 2023 | 00:23h | UTC

Malignant Neoplasms of the Gastrointestinal Tract After Blood or Marrow Transplant – JAMA Oncology (link to abstract – $ for full-text)

Commentary: Risk of Subsequent Gastrointestinal Tract Malignancies After Blood or Marrow Transplantation – The ASCO Post

 

Commentary on Twitter

 


Salivary gland cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

27 Jan, 2023 | 12:16h | UTC

Salivary gland cancer: ESMO–European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up – ESMO Open

 


M-A | Sensitivity and complications of thoracentesis and thoracoscopy for the diagnosis of malignant pleural effusions

27 Jan, 2023 | 12:11h | UTC

Sensitivity and complications of thoracentesis and thoracoscopy: a meta-analysis – European Respiratory Review

 


Diagnostic Study | Usefulness of CT radiomics in differentiating histologic subtypes of epithelial ovarian carcinoma

27 Jan, 2023 | 12:01h | UTC

Computed Tomographic Radiomics in Differentiating Histologic Subtypes of Epithelial Ovarian Carcinoma – JAMA Network Open

 

Commentary on Twitter

 


M-A | Proximal gastrectomy with double-tract-reconstruction vs. total gastrectomy in gastric and gastroesophageal junction cancer patients

27 Jan, 2023 | 11:54h | UTC

Systematic review and meta-analysis comparing proximal gastrectomy with double-tract-reconstruction and total gastrectomy in gastric and gastroesophageal junction cancer patients: Still no sufficient evidence for clinical decision-making – Surgery

 


Pre-existing autoimmune disease increases the risk of cardiovascular and noncardiovascular events after immunotherapy

26 Jan, 2023 | 12:09h | UTC

Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After Immunotherapy – JACC: CardioOncology

Commentary: Preexisting Autoimmune Disease and Risk for Cardiovascular Events in Patients Receiving Immune Checkpoint Inhibitor Therapy for Cancer – The ASCO Post

 


Review | Lung cancer screening: new evidence, updated guidance

26 Jan, 2023 | 12:08h | UTC

Lung cancer screening: New evidence, updated guidance – Journal of Family Practice

 


Perspective | Endocrine treatment for 5 years or radiation for 5 days for patients with early breast cancer older than 65 years

26 Jan, 2023 | 12:04h | UTC

Endocrine Treatment for 5 Years or Radiation for 5 Days for Patients With Early Breast Cancer Older Than 65 Years: Can We Do It Right? – Journal of Clinical Oncology

 

Commentary from the author on Twitter

 


RCT | Postoperative adjuvant hepatic arterial infusion chemotherapy with FOLFOX in hepatocellular carcinoma with microvascular invasion

26 Jan, 2023 | 12:03h | UTC

Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study – Journal of Clinical Oncology

 


RCT | Preoperative chemotherapy reduced recurrence in operable colon cancer

25 Jan, 2023 | 11:29h | UTC

Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial – Journal of Clinical Oncology

Editorial: FOxTROT: Are We Ready to Dance? – Journal of Clinical Oncology

News Release: Chemotherapy before surgery cuts risk of colon cancer returning, trial finds – Cancer Research UK

Commentary: New treatment strategy cuts risk of bowel cancer returning by 28% – The Guardian

 

Commentary from one of the authors on Twitter (thread – click for more)

 


Consensus Paper | Tumor surveillance guidelines for individuals with neurofibromatosis type 1

25 Jan, 2023 | 11:24h | UTC

ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1 – eClinicalMedicine

 


Single-arm phase 2 study | Neoadjuvant pembrolizumab in localized microsatellite instability high/deficient mismatch repair solid tumors

24 Jan, 2023 | 14:19h | UTC

Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors – Journal of Clinical Oncology (link to abstract – $ for full-text)

Editorial: Immunotherapy in Localized Microsatellite Instability–High/Mismatch Repair Deficient Solid Tumors: Are We Ready for a New Standard of Care? – Journal of Clinical Oncology

Commentary: Neoadjuvant Pembrolizumab in Localized MSI-H/dMMR Solid Tumors – The ASCO Post

 


RCT | Breast-cancer–related lymphedema after reverse lymphatic mapping and selective axillary dissection vs. standard surgical treatment of axilla

24 Jan, 2023 | 14:15h | UTC

Occurrence of breast-cancer–related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two-arm randomized clinical trial – Cancer

 

Commentary on Twitter

 


Meta-analysis reaffirms benefits of O-RADS MRI for diagnosing indeterminate adnexal lesions

24 Jan, 2023 | 14:05h | UTC

Commentary: Meta-Analysis Reaffirms Benefits of O-RADS MRI for Diagnosing Indeterminate Adnexal Lesions – Diagnostic Imaging

Original Study: O-RADS MRI: A Systematic Review and Meta-Analysis of Diagnostic Performance and Category-wise Malignancy Rates – Radiology (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Stay Updated in Your Specialty

No spam, just news.